EMBLA Stock Overview
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for EMBLA from our risk checks.
Embla Medical hf. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.29.50 |
| 52 Week High | kr.35.70 |
| 52 Week Low | kr.25.25 |
| Beta | 0.59 |
| 1 Month Change | -11.94% |
| 3 Month Change | 0.51% |
| 1 Year Change | -5.14% |
| 3 Year Change | -35.52% |
| 5 Year Change | -11.68% |
| Change since IPO | 436.36% |
Recent News & Updates
A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)
Apr 10
Is Össur hf (CPH:OSSR) Using Too Much Debt?
Mar 23Recent updates
A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)
Apr 10Is Össur hf (CPH:OSSR) Using Too Much Debt?
Mar 23Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E
Jan 21Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 03Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Nov 28Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Nov 08A Look At The Fair Value Of Össur hf. (CPH:OSSR)
Sep 23We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt
Aug 21Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital
Jul 18Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 14Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
May 19Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Mar 14A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 21These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well
Dec 22There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Dec 07Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?
Sep 21Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Sep 02Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Aug 16Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price
Jun 16Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends
Jun 01Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?
May 08Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around
Feb 22Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report
Feb 03Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Nov 25Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Oct 17Is Össur hf (CPH:OSSR) A Risky Investment?
Sep 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Aug 21Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Jul 11Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly
May 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
May 07There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Mar 25We Think The Compensation For Össur hf.'s (CPH:OSSR) CEO Looks About Right
Mar 02We Think Össur hf (CPH:OSSR) Can Stay On Top Of Its Debt
Feb 22Does The Market Have A Low Tolerance For Össur hf.'s (CPH:OSSR) Mixed Fundamentals?
Feb 09What Kind Of Shareholders Own Össur hf. (CPH:OSSR)?
Jan 26Össur hf (CPH:OSSR) Shareholders Have Enjoyed An Impressive 115% Share Price Gain
Jan 08
We're Watching These Trends At Össur hf (CPH:OSSR)
Dec 21Shareholder Returns
| EMBLA | DK Medical Equipment | DK Market | |
|---|---|---|---|
| 7D | -1.7% | -3.0% | -0.3% |
| 1Y | -5.1% | 0.5% | 23.7% |
Return vs Industry: EMBLA underperformed the Danish Medical Equipment industry which returned 0.5% over the past year.
Return vs Market: EMBLA underperformed the Danish Market which returned 23.7% over the past year.
Price Volatility
| EMBLA volatility | |
|---|---|
| EMBLA Average Weekly Movement | 4.4% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in DK Market | 9.1% |
| 10% least volatile stocks in DK Market | 2.9% |
Stable Share Price: EMBLA has not had significant price volatility in the past 3 months.
Volatility Over Time: EMBLA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1971 | 3,999 | Sveinn Solvason | www.ossur.com |
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics, Bracing & Supports, and Patient Care. The Prosthetics segment offers mechanical products, such as lower limb prosthetics and finger prostheses; and bionic products microprocessor-controlled feet, knees, hands, liners, fingers, and other components integrated.
Embla Medical hf. Fundamentals Summary
| EMBLA fundamental statistics | |
|---|---|
| Market cap | kr.12.59b |
| Earnings (TTM) | kr.409.34m |
| Revenue (TTM) | kr.5.51b |
30.8x
P/E Ratio2.3x
P/S RatioIs EMBLA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EMBLA income statement (TTM) | |
|---|---|
| Revenue | US$785.68m |
| Cost of Revenue | US$300.11m |
| Gross Profit | US$485.57m |
| Other Expenses | US$427.18m |
| Earnings | US$58.39m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 23, 2024
| Earnings per share (EPS) | 0.14 |
| Gross Margin | 61.80% |
| Net Profit Margin | 7.43% |
| Debt/Equity Ratio | 47.3% |
How did EMBLA perform over the long term?
See historical performance and comparison